Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study

Sabrina Bajwah, Joanna M. Davies, Hanan Tanash, David C. Currow, Adejoke O. Oluyase, Magnus Ekström

Source: Eur Respir J, 52 (6) 1801278; 10.1183/13993003.01278-2018
Journal Issue: December
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sabrina Bajwah, Joanna M. Davies, Hanan Tanash, David C. Currow, Adejoke O. Oluyase, Magnus Ekström. Safety of benzodiazepines and opioids in interstitial lung disease: a national prospective study. Eur Respir J, 52 (6) 1801278; 10.1183/13993003.01278-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Indications and patterns of use of benzodiazepines and opioids in severe interstitial lung disease: a population-based longitudinal study
Source: ERJ Open Res, 7 (1) 00716-2020; 10.1183/23120541.00716-2020
Year: 2021



Long-acting bronchodilator initiation in COPD and cardio-pulmonary risks: A population-based comparative effectiveness study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016


Use of national disease registries in the conduct of long-term post-authorisation drug safety studies (LTSSs)
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016

Efficacy and safety of erdosteine in COPD: Results of a 12-month prospective, multinational study
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Safety and effectiveness of indacaterol in Korean COPD patients: A post-marketing surveillance (PMS) study
Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD
Year: 2015

The patterns of inadequate drug administration in children with asthma: a multi-center retrospective study
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002

Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019
Year: 2020



An electronic alert to reduce excessive prescribing of short-acting beta2-agonists for people with asthma in East London: a retrospective case-control study using routine primary care data
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020


Use of antidepressive agents in COPD patients: experience in a large Canadian cohort
Source: Annual Congress 2008 - Comorbidities in COPD
Year: 2008


Use of inhaled corticosteroids and the risk of osteoporosis: an international cohort study
Source: International Congress 2018 – Epidemiology of asthma, COPD and factors that associate with lung function
Year: 2018

Safety and benefits of beta-blockers in chronic obstructive pulmonary disease: a review of current evidence and meta-analysis
Source: International Congress 2018 – Cardiovascular morbidities in COPD
Year: 2018

Feasibility of home spirometry in patients with chronic graft-versus-host disease: a prospective observational study
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020


Costs and effects of structured COPD care – An observational, matched-cohort study
Source: Annual Congress 2013 –Early diagnosis and effectiveness of disease management in primary care
Year: 2013

An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study
Source: ERJ Open Res, 5 (1) 00175-2018; 10.1183/23120541.00175-2018
Year: 2019



Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases)
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

Inhaled corticosteroids and the risk of lung cancer in COPD: a population-based cohort study
Source: Eur Respir J, 53 (6) 1801257; 10.1183/13993003.01257-2018
Year: 2019



Interstitial lung diseases in children: The French national cohort study
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011

A non-interventional observational trial to study the COPD treatment choices in routine clinical practice in Bulgaria
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016